文献速递中毒与环境急症心脑血管急症

药物中毒相关QRS波群延长趋势的演变

Evolving trends of pharmaceutical poisonings associated with QRS complex prolongation.
PubMed 文献 · Clin Toxicol (Phila) · 2024-08-28
一句话结论当代药物中毒中,三环类抗抑郁药致QRS延长的占比下降,氟卡尼、安非他酮、苯海拉明等日益常见。

该研究为Toxicology Investigators Consortium(ToxIC)Core Registry数据的二次分析,纳入2016年1月至2023年3月就诊的成人急性或急性叠加慢性药物暴露患者。主要结局为QRS波群延长>0.12 s,采用多因素logistic回归分析各药物与QRS延长的独立关联。11945例总队列中366例(3.1%)发生QRS延长;模型纳入9417例中290例(3.1%)发生QRS延长。阿米替林、去甲替林、多塞平、丙米嗪、诺昔替林、安非他酮、氟卡尼、卡维地洛、普萘洛尔、苯海拉明和拉莫三嗪中毒为QRS延长的独立预测因素,其中氟卡尼中毒的比值比最高(OR 574.1;95%CI 88.3-12747)。三环类抗抑郁药对QRS延长的贡献从2016年的38.8%降至2022年的17.6%,2022年苯海拉明所致QRS延长比例(20.6%)超过三环类抗抑郁药。

要点

  • 氟卡尼中毒致QRS延长风险最高:OR 574.1(95%CI 88.3-12747),为独立预测因素。
  • 三环类抗抑郁药对QRS延长的贡献从2016年38.8%降至2022年17.6%。
  • 2022年苯海拉明所致QRS延长比例达20.6%,超过三环类抗抑郁药。
  • 安非他酮、苯海拉明和抗心律失常药是日益常见的QRS延长原因,各与多种严重结局相关。

适用人群与场景

  • 2016年1月至2023年3月就诊的成人急性或急性叠加慢性药物暴露患者(ToxIC Core Registry数据)。

诊断标准与关键阈值

  • QRS波群延长定义为>0.12 s。

研究设计与关键结果

  • 研究类型:ToxIC Core Registry数据的二次分析;总队列11945例(中位年龄37岁,6652例[55.7%]女性),366例(3.1%)发生QRS延长;模型纳入9417例,290例(3.1%)发生QRS延长。
  • 独立预测QRS延长的药物:阿米替林、去甲替林、多塞平、丙米嗪、诺昔替林、安非他酮、氟卡尼、卡维地洛、普萘洛尔、苯海拉明、拉莫三嗪。
  • 氟卡尼中毒致QRS延长的OR最高:OR 574.1(95%CI 88.3-12747)。
  • 三环类抗抑郁药对QRS延长的贡献从2016年38.8%降至2022年17.6%。
  • 2022年苯海拉明所致QRS延长比例为20.6%,超过三环类抗抑郁药。

证据类型、等级与局限

  • 证据类型:基于多中心注册数据库(ToxIC Core Registry)的二次分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,安非他酮、苯海拉明和抗心律失常药是日益常见的QRS延长原因,各与中毒时的多种严重结局相关。
  • 作者认为,需要采取更严格的安全措施以保护患者免受这些药物引起的心血管毒性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Tricyclic antidepressants often cause drug-induced QRS complex prolongation in overdose but are now less commonly prescribed. We sought to determine, among a contemporary cohort of patients, the pharmaceuticals independently associated with QRS complex prolongation in acute overdose.

METHODS: We performed secondary analysis of data from the Toxicology Investigators Consortium (ToxIC) Core Registry. We included adult patients presenting from January 2016 through March 2023 with acute or acute-on-chronic pharmaceutical exposures. The primary outcome was QRS complex prolongation >0.12 s. Secondary outcomes included cardiac arrest, death, ventricular dysrhythmia, intensive care unit admission, initiation of vasopressors, and treatment with sodium bicarbonate. We used a multivariable logistic regression model with QRS complex prolongation as the outcome and individual pharmaceuticals of interest as independent variables. We assessed yearly trends of the contribution of relevant pharmaceuticals to QRS complex prolongation since 2016.

RESULTS: Of 11,945 patients in the total cohort (median age 37 years, 6,652 [55.7%] female), 366 (3.1%) developed QRS complex prolongation. Of 9,417 patients included in the model, 290 (3.1%) developed QRS complex prolongation. Amitriptyline, nortriptyline, doxepin, imipramine, noxiptiline, bupropion, flecainide, carvedilol, propranolol, diphenhydramine, and lamotrigine poisonings were independent predictors of QRS complex prolongation. Flecainide poisoning conferred the greatest odds of QRS complex prolongation (OR 574.1; 95% CI: 88.3-12,747). The contribution of tricyclic antidepressants to QRS complex prolongation decreased from 38.8% to 17.6% of all patients with QRS complex prolongation from 2016 to 2022. In 2022, the proportion of QRS complex prolongation from diphenhydramine (20.6%) surpassed that of tricyclic antidepressants.

DISCUSSION: This study provides insights into contemporary pharmaceutical poisoning associated with QRS complex prolongation. Tricyclic antidepressants remain clinically relevant exposures but are no longer the most common cause of drug-induced QRS complex prolongation.

CONCLUSIONS: Bupropion, diphenhydramine, and antidysrhythmics are increasingly common causes of QRS complex prolongation, each associated with numerous severe outcomes in poisoning. Greater safety measures to protect patients from cardiovascular toxicity from these pharmaceuticals are warranted.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Tang KB, Simpson MD, Burns MM, et al. Evolving trends of pharmaceutical poisonings associated with QRS complex prolongation. Clin Toxicol (Phila). 2024. PMID: 39194962. doi:10.1080/15563650.2024.2390138

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。